152 related articles for article (PubMed ID: 6291622)
1. Prostacyclin prolongs viability of washed human platelets.
Blackwell GJ; Radomski M; Vargas JR; Moncada S
Biochim Biophys Acta; 1982 Sep; 718(1):60-5. PubMed ID: 6291622
[TBL] [Abstract][Full Text] [Related]
2. Stimulated platelet aggregation, thromboxane B2 formation and platelet sensitivity to prostacyclin - a critical evaluation.
Siess W; Roth P; Weber PC
Thromb Haemost; 1981 Jun; 45(3):204-7. PubMed ID: 7025338
[TBL] [Abstract][Full Text] [Related]
3. Biological actions of prostacyclin and its pharmacological use in platelet studies.
Moncada S; Whittle BJ
Adv Exp Med Biol; 1985; 192():337-58. PubMed ID: 3010671
[No Abstract] [Full Text] [Related]
4. Modulation of human platelet function by prostacyclin and thromboxane A2.
Gorman RR
Fed Proc; 1979 Jan; 38(1):83-8. PubMed ID: 215465
[No Abstract] [Full Text] [Related]
5. Simvastatin reduces platelet thromboxane formation and restores normal platelet sensitivity against prostacyclin in type IIa hypercholesterolemia.
Schrör K; Löbel P; Steinhagen-Thiessen E
Eicosanoids; 1989; 2(1):39-45. PubMed ID: 2483819
[TBL] [Abstract][Full Text] [Related]
6. Acetyl glycerylphosphorylcholine inhibition of prostaglandin I2-stimulated adenosine 3',5'-cyclic monophosphate levels in human platelets. Evidence for thromboxane A2 dependence.
Miller OV; Ayer DE; Gorman RR
Biochim Biophys Acta; 1982 Jun; 711(3):445-51. PubMed ID: 6285985
[TBL] [Abstract][Full Text] [Related]
7. Effects of adenosine 3':5'-monophosphate and platelet aggregation on thromboxane biosynthesis in human platelets.
Lindgren JA; Claesson HE; Kindahl H; Hammarström S
FEBS Lett; 1979 Feb; 98(2):247-50. PubMed ID: 217731
[No Abstract] [Full Text] [Related]
8. Role of cyclic AMP in the inhibition of human platelet aggregation by quercetin, a flavonoid that potentiates the effect of prostacyclin.
Beretz A; Stierle A; Anton R; Cazenave JP
Biochem Pharmacol; 1982 Nov; 31(22):3597-600. PubMed ID: 6295405
[TBL] [Abstract][Full Text] [Related]
9. Effects of platelet aggregation and adenosine 3':5'-monophosphate on the synthesis of thromboxane B2 in human platelets.
Lindgren JA; Claesson HE; Kindahl H; Hammarström S
Adv Prostaglandin Thromboxane Res; 1980; 6():275-81. PubMed ID: 6247886
[No Abstract] [Full Text] [Related]
10. Is prostacyclin a physiologically important circulating anti-platelet agent?
Steer ML; MacIntyre DE; Levine L; Salzman EW
Nature; 1980 Jan; 283(5743):194-5. PubMed ID: 6243178
[No Abstract] [Full Text] [Related]
11. An ultrastructural study of stored human platelets after washing using prostacyclin.
Read NG; Radomski MW; Goodwin DA; Moncada S
Br J Haematol; 1985 Jun; 60(2):305-14. PubMed ID: 3890933
[TBL] [Abstract][Full Text] [Related]
12. Stabilization of standard platelet concentrates and minimization of the platelet storage lesion by a prostacyclin analogue.
Elias M; Heethuis A; Weggemans M; Bom V; Blom N; McShine RL; Halie MR; Smit Sibinga CT
Ann Hematol; 1992 Jun; 64(6):292-8. PubMed ID: 1379080
[TBL] [Abstract][Full Text] [Related]
13. Prostacyclin analogs: antiaggregatory potency and enhancement of cAMP levels in human platelet rich plasma.
Dembinska-Kiec A; Rücker W; Schönhöfer PS; Gandolfi C
Thromb Haemost; 1979 Dec; 42(4):1340-3. PubMed ID: 232318
[No Abstract] [Full Text] [Related]
14. Reciprocal regulation of human platelet cAMP levels by thromboxane A2 and prostacyclin.
Gorman RR; Fitzpatrick FA; Miller OV
Adv Cyclic Nucleotide Res; 1978; 9():597-609. PubMed ID: 208399
[No Abstract] [Full Text] [Related]
15. Inhibitory effects of ZK 36374, a stable prostacyclin analogue, on adhesion of rabbit platelets to damaged aorta and serotonin release by adherent platelets.
Menys VC; Davies JA
Clin Sci (Lond); 1983 Aug; 65(2):149-53. PubMed ID: 6190604
[TBL] [Abstract][Full Text] [Related]
16. Organic nitrates: direct antiplatelet effects and synergism with prostacyclin. Antiplatelet effects of organic nitrates.
De Caterina R; Giannessi D; Bernini W; Mazzone A
Thromb Haemost; 1988 Apr; 59(2):207-11. PubMed ID: 3291182
[TBL] [Abstract][Full Text] [Related]
17. Isolation and washing of human platelets with nitric oxide.
Radomski MW; Palmer RM; Read NG; Moncada S
Thromb Res; 1988 May; 50(4):537-46. PubMed ID: 2842884
[TBL] [Abstract][Full Text] [Related]
18. Decreased prostacyclin sensitivity of platelets in patients with Behçet's syndrome.
Wilson AP; Efthimiou J; Betteridge DJ
Eur J Clin Invest; 1988 Aug; 18(4):410-4. PubMed ID: 2971547
[TBL] [Abstract][Full Text] [Related]
19. Triene prostaglandins: prostacyclin and thromboxane biosynthesis and unique biological properties.
Needleman P; Raz A; Minkes MS; Ferrendelli JA; Sprecher H
Proc Natl Acad Sci U S A; 1979 Feb; 76(2):944-8. PubMed ID: 218223
[TBL] [Abstract][Full Text] [Related]
20. Changes in some aspects of platelet function with improvement of glycaemic control over 6 months.
Collier A; Tymkewycz PM; Matthews DM; Jones RL; Clarke BF
Diabetes Res; 1987 Jun; 5(2):79-82. PubMed ID: 2443296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
